Recurrent venous thromboembolism: a role for ABO blood group?

Francesco Dentali; Massimo Franchini

doi:10.1160/TH13-09-0780

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2013; 110(06): 1110-1111
DOI: 10.1160/TH13-09-0780

Invited Editorial Focus

Schattauer GmbH

Recurrent venous thromboembolism: a role for ABO blood group?

Authors

Francesco Dentali

¹Department of Clinical and Experimental Medicine University of Insubria, Varese, Italy
Massimo Franchini

²Department of Transfusion Medicine and Hematology, “C. Poma” Hospital, Mantova, Italy

Abstract

Full Text

References

References
1 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (Suppl. 23) I4-8.
2 Kyrle PA, Eichinger S. Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost 2012; 108: 1061-1064.
3 Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials. Thromb Haemost 2012; 108: 1042-1048.
4 Spyropoulos AC, McGinn T, Khorana AA. The use of weighted and scored risk assessment models for venous thromboembolism. Thromb Haemost 2012; 108: 1072-1076.
5 Ageno W, Dentali F, Donadini MP, Squizzato A. Optimal treatment duration of venous thrombosis. J Thromb Haemost 2013; 11 (Suppl. 01) 151-160.
6 Angchaisuksiri P. Venous thromboembolism in Asia - an unrecognised and under-treated problem?. Thromb Haemost 2011; 106: 585-590.
7 Wattanakit K, Lutsey PL, Bell EJ. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012; 108: 508-515.
8 Bergrem A, Dahm AE, Jacobsen AF. et al. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study. Thromb Haemost 2012; 108: 1165-1171.
9 Franchini M, Favaloro EJ, Targher G. et al. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49: 137-149.
10 Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 2013; 51: 1545-1553.
11 Moeller A, Weippert-Kretschmer M, Prinz H. et al. Influence of ABO blood groups on primary hemostasis. Transfusion 2001; 41: 56-60.
12 Gill JC, Endres-Brooks J, Bauer PJ. et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-1695.
13 Wu O, Bayoumi N, Vickers MA. et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-69.
14 Dentali F, Sironi AP, Ageno W. et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a metaanalysis of the literature. Semin Thromb Hemost 2012; 38: 535-548.
15 Muellner SK, Haut ER, Streiff MB. et al. ABO blood group as a potential risk factor for venous thromboembolism in acutely injured patients. Thromb Haemost 2011; 105: 5-13.
16 Jang MJ, Yhim HY, Lee JO. et al. ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population. A report from the Korean Venous Thromboembolism Working Party (KVTEWP). Thromb Haemost 2012; 107: 799-801.
17 Tufano A, Coppola A, Nardo A. et al. Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost 2013; 110: 197-199.
18 Le Gal G, Kovacs MJ, Carrier M. et al. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost 2010; 104: 498-503.
19 Lecumberri R, Alfonso A, Jiménez D. et al. and the RIETE investigators. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost. 2013 110. Epub ahead of print.
20 Rodger MA, Kahn SR, Wells PS. et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 179: 417-426.
21 Gandara E, Kovacs MJ, Kahn KR. et al. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost 2013; 110: 1172-1179.
22 Dentali F, Di Minno MND, Turato S. et al. Role of ABO blood group and of thrombophilic abnormalities on the presence of residual vein obstruction after deep-vein thrombosis of the lower limbs. J Thromb Haemost 2013; 11 (Suppl. 02) 392 (abstract).
23 Cosmi B, Legnani C, Pengo V. et al. PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs. Thromb Haemost 2013; 109: 510-516.